People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nectero Medical Inc | — | Biotechnology | Series B | $52.5M | $259.1M | 2024 |
| Laplace Interventional, Inc. | — | Other Health Care | Series B | $42.0M | $114.8M | 2025 |
Colin Morrison at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Colin Morrison on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Roberts | 1 | 9 |
| WILLIAM DAI | 1 | 8 |
| Robert Whirley | 1 | 4 |
| John Springer | 1 | 2 |
| Anil Dasu | 1 | 2 |
| Ramji Iyer | 1 | 1 |
| Jenny Barba | 1 | 1 |
| Jenny H. Barba | 1 | 1 |
| Bryan Ziegler | 1 | 1 |
| Jack Springer | 1 | 1 |
| Todd Mortier | 1 | 1 |
| Todd H. Mortier | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.